Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, p. annrheumdis-2021-220857, 2021
DOI: 10.1136/annrheumdis-2021-220857
Links
Tools
Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhiret al
Journal article published in 2021 by
Veerle Stouten 
,
René Westhovens ,
Sofia Pazmino ,
Diederik De Cock ,
Kristien Van der Elst,
Johan Joly ,
Delphine Bertrand,
Patrick Verschueren
,
René Westhovens ,
Sofia Pazmino ,
Diederik De Cock ,
Kristien Van der Elst,
Johan Joly ,
Delphine Bertrand,
Patrick Verschueren
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 